RxSight, Inc. (RXST) Tops Q1 EPS by 17c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- Wall Street indexes slip as oil prices rise, retail results awaited
- Trump threatens to bomb Oman over Iran stance
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Micron rises as White House presses Apple to avoid Chinese memory chips
- Wall Street indexes slip as oil prices rise, retail results awaited
- Trump threatens to bomb Oman over Iran stance
- L3Harris CEO steps down amid conduct review, shares drop
- Oil settles up over $2 as Iran war stalemate stokes supply concerns
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
RxSight Inc. (RXST) PT Raised to $75 at Stifel
May 7, 2024 6:04 AM EDTStifel analyst Tom Stephan raised the price target on RxSight Inc. (NASDAQ: RXST) to $75.00 (from $68.00) while maintaining a Buy rating.
The analyst comments "RXSTs 1Q24 results confirmed (and then some) why it has been viewed as one of the best 2024 momentum stories... More
RxSight Inc. (RXST) PT Raised to $68 at Wells Fargo
May 7, 2024 5:53 AM EDTWells Fargo analyst Lawrence Biegelsen raised the price target on RxSight Inc. (NASDAQ: RXST) to $68.00 (from $61.00) while maintaining a Overweight rating.
The analyst comments "We raise our 2024 EPS estimate from -$1.02 to -$0.86. Our price target increases to $68 (from $61) based on 13x (from 11x... More
RxSight Inc. (RXST) PT Raised to $72 at BTIG
May 7, 2024 5:19 AM EDTBTIG analyst Ryan Zimmerman raised the price target on RxSight Inc. (NASDAQ: RXST) to $72.00 (from $61.00) while maintaining a Buy rating.
The analyst comments "We reiterate our Buy and raise our PT to $72 PT (from $61) following 1Q24 results. RXST delivered a strong start to FY24 with 1Q24 revenue of $29.5M (69% Y/Y) and adj. LPS of $(0.25)... More
